1. Home
  2. NRT vs CPIX Comparison

NRT vs CPIX Comparison

Compare NRT & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NRT

North European Oil Royality Trust

HOLD

Current Price

$6.35

Market Cap

59.6M

Sector

Energy

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$4.05

Market Cap

34.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRT
CPIX
Founded
1975
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.6M
34.1M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
NRT
CPIX
Price
$6.35
$4.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
40.5K
224.3K
Earning Date
12-30-2025
11-04-2025
Dividend Yield
12.90%
N/A
EPS Growth
24.05
N/A
EPS
0.59
N/A
Revenue
$6,184,173.00
$41,278,349.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.71
N/A
Revenue Growth
18.55
12.21
52 Week Low
$3.90
$1.85
52 Week High
$6.95
$7.25

Technical Indicators

Market Signals
Indicator
NRT
CPIX
Relative Strength Index (RSI) 52.89 73.82
Support Level $6.10 $3.93
Resistance Level $6.51 $4.59
Average True Range (ATR) 0.19 0.42
MACD -0.00 0.16
Stochastic Oscillator 43.75 80.28

Price Performance

Historical Comparison
NRT
CPIX

About NRT North European Oil Royality Trust

North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: